"#000000","#ffffff","#10222c","#287da4","#5a8128","#484848","#626262","#bbbdbf","#f69320","#f06724","#00838a","#008b93","#5cc9f3","#2a3b8f","#1b1b1b","#3e3e3e","#148e95","#008b92","#f6931f","#f06724","#2a3b8f","#282d77","#55a0d0","#3192c1","#0077a5","#1c76bc","#116bb2","#d91a5d","#b41764","#6b308d"
CMP Pharma, Inc Announces that Atorvaliq®, the First and Only FDA-approved Liquid Suspension of Atorvastatin is Now Available
CMP Pharma, Inc. Announces Unit Dose Packaging for CaroSpir®, The First and Only FDA-Approved Spironolactone Oral Suspension
CMP Pharma, Inc Announces That CaroSpir®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available
CMP Pharma, Inc. Announces FDA Approval of CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL)
CMP Pharma and Generic Specialty Pharma Sign Product Development Agreement
TRIANEX® 0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma®, LLC
Carolina Medical Products Now CMP Pharma
CMP Pharma and Kiel Laboratories Sign Development Agreement for Two NDA Products
